Cardiovascular Outcomes with Sotagliflozin
- PMID: 33852786
- DOI: 10.1056/NEJMc2102961
Cardiovascular Outcomes with Sotagliflozin
Comment in
-
Cardiovascular Outcomes with Sotagliflozin. Reply.N Engl J Med. 2021 Apr 15;384(15):1471-1473. doi: 10.1056/NEJMc2102961. N Engl J Med. 2021. PMID: 33852788 No abstract available.
Comment on
-
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.N Engl J Med. 2021 Jan 14;384(2):129-139. doi: 10.1056/NEJMoa2030186. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200891 Clinical Trial.
-
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.N Engl J Med. 2021 Jan 14;384(2):117-128. doi: 10.1056/NEJMoa2030183. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200892 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical